Attending Physician of Jiangsu Provincial People’s Hospital, China
Dr. Shi Xiaoli, originally from Jiangsu, China, is a distinguished scholar in the field of surgery. 🌟 With a Ph.D. from Southeast University, in collaboration with Nanjing Medical University, Dr. Shi has demonstrated exceptional expertise and dedication in his field. 🎓 His academic journey includes a master’s degree in surgery from Nanjing Medical University, under the mentorship of esteemed advisors Wang Xuehao, Li Xiangcheng, and Yu Yue. 👨🏫👩🏫 Currently residing in Gulou District, Nanjing, Dr. Shi holds professional certifications and has completed standard training. 🏠👨⚕️ His contributions to the medical field are marked by a commitment to advancing surgical practices and knowledge.
Professional profile
Education📚
Dr. Shi Xiaoli’s educational journey is marked by significant achievements in the field of surgery. 🎓 He pursued his doctoral studies at Southeast University, in collaboration with Nanjing Medical University, where he earned his Ph.D. in Surgery from September 2021 to July 2024. 📜 Prior to this, he completed his Master’s degree in Surgery at Nanjing Medical University from September 2018 to July 2021. 🏅 Dr. Shi’s academic background reflects a deep commitment to advancing his expertise and contributing to the field of medical science.
Professional Experience🏛️
Dr. Shi Xiaoli has accumulated extensive professional experience in the field of surgery. 💼 His career is distinguished by significant contributions to medical practice and research, underscoring his expertise and dedication. 🏥 With a robust foundation in clinical and academic settings, Dr. Shi has honed his skills through rigorous training and hands-on experience, establishing himself as a knowledgeable and proficient surgeon. 🩺 His professional journey reflects a strong commitment to enhancing patient care and advancing surgical techniques. 🌟
Research Interest🌐
Dr. Shi Xiaoli is deeply engaged in research within the field of surgery, focusing on advancing surgical techniques and improving patient outcomes. 🔬 His interests span innovative surgical methods, disease treatment advancements, and the integration of cutting-edge technologies in medical practice. 🏥💡 Driven by a commitment to enhancing surgical precision and efficacy, Dr. Shi explores new approaches to surgery and strives to contribute valuable insights to the medical community. 📊🔍 His research aims to address current challenges in the field and push the boundaries of surgical science. 🌟
Awards and Honors🏆
Dr. Shi Xiaoli has received several prestigious awards and honors, reflecting his excellence and dedication in the field of surgery. 🏆 His achievements include notable recognitions for outstanding research and contributions to medical science. 🌟 Among his accolades are esteemed awards from professional medical associations and institutions, highlighting his impact and leadership in the field. 🏅✨ These honors not only celebrate his academic and clinical accomplishments but also underscore his commitment to advancing surgical practices and patient care. 🏥👏
Research skill🔬
Dr. Shi Xiaoli possesses a robust set of research skills that underscore his expertise in the field of surgery. 🔬 He excels in designing and conducting rigorous studies, utilizing advanced methodologies to explore surgical techniques and patient care innovations. 📊 With a keen eye for detail and a commitment to precision, Dr. Shi employs sophisticated analytical tools and technologies to derive meaningful insights from his research. 💡 His ability to critically evaluate data and integrate findings into practical applications reflects his deep understanding of both clinical and academic aspects of surgery. 🏥🔍 His research skills contribute significantly to advancing medical science and improving surgical outcomes. 🌟📈
Achievements🏅
- 🎓 Ph.D. in Surgery from Southeast University (Jointly trained with Nanjing Medical University)
- 🏅 Master’s Degree in Surgery from Nanjing Medical University
- 🩺 Professional Certification in Surgery
- 👨⚕️ Completed Standard Training in clinical practice
- 🌟 Significant Contributions to surgical techniques and patient care innovations
- 🔬 Advanced Research in surgical methods and technologies
Projects🛠️
- 🏥 Innovative Surgical Techniques: Development and implementation of new methods to improve surgical outcomes.
- 🔬 Advanced Research Studies: Exploration of cutting-edge technologies and approaches in surgery.
- 📊 Patient Care Enhancements: Projects focused on optimizing patient care through improved surgical practices.
- 💡 Technology Integration: Incorporation of advanced technologies into surgical procedures and treatment plans.
- 🧪 Clinical Trials: Conducting trials to assess the efficacy and safety of new surgical techniques and treatments.
Publication📜
- RAC1^high NK cell-based immunotherapy in hepatocellular carcinoma via STAT3-NKG2D axis
- 📝 Authors: Shi, X., Chen, W., Yin, Y., Yu, Y., Wang, X.
- 📅 Year: 2024
- 🗞️ Journal: Cancer Letters
- 📈 Citations: 0
- Cuproptosis-associated genes (CAGs) contribute to the prognosis prediction and potential therapeutic targets in hepatocellular carcinoma
- 📝 Authors: Shi, X., Shi, D., Yin, Y., Yu, Y., Wang, X.
- 📅 Year: 2024
- 🗞️ Journal: Cellular Signalling
- 📈 Citations: 0
- MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex
- 📝 Authors: Jiang, W., Yang, X., Shi, K., Li, C., Li, X.
- 📅 Year: 2023
- 🗞️ Journal: Oncogene
- 📈 Citations: 3
- Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners
- 📝 Authors: Li, Q., Zhang, L., Yang, Q., Zhang, P., Wang, X.
- 📅 Year: 2023
- 🗞️ Journal: Cell Metabolism
- 📈 Citations: 10
- KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1/YBX1 mediated NF-κB pathway in cholangiocarcinoma
- 📝 Authors: Jiang, W., Wang, J., Yang, X., Li, C., Li, X.
- 📅 Year: 2023
- 🗞️ Journal: Oncogene
- 📈 Citations: 8
- Exosomal lncRNA HCG18 contributes to cholangiocarcinoma growth and metastasis through mediating miR-424-5p/SOX9 axis through PI3K/AKT pathway
- 📝 Authors: Ni, Q., Zhang, H., Shi, X., Li, X.
- 📅 Year: 2023
- 🗞️ Journal: Cancer Gene Therapy
- 📈 Citations: 13
- Exosomal miR-30a-5p promoted intrahepatic cholangiocarcinoma progression by increasing angiogenesis and vascular permeability in PDCD10 dependent manner
- 📝 Authors: Jiang, W., Shi, X., Sun, L., Li, C., Li, X.
- 📅 Year: 2023
- 🗞️ Journal: International Journal of Biological Sciences
- 📈 Citations: 1
- NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1
- 📝 Authors: Shan, J., Jiang, W., Chang, J., Li, C., Li, X.
- 📅 Year: 2023
- 🗞️ Journal: International Journal of Biological Sciences
- 📈 Citations: 6
- CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ
- 📝 Authors: Hao, X., Zhang, Y., Shi, X., Tang, W., Wang, X.
- 📅 Year: 2022
- 🗞️ Journal: Journal of Experimental and Clinical Cancer Research
- 📈 Citations: 32
- ROBO1 p.E280 Loses the Inhibitory Effects on the Proliferation and Angiogenesis of Wild-Type ROBO1 in Cholangiocarcinoma by Interrupting SLIT2 Signal*
- 📝 Authors: Zhou, T., Zhang, Y., Chen, Y., Li, C., Li, X.
- 📅 Year: 2022
- 🗞️ Journal: Frontiers in Oncology
- 📈 Citations: 2
